CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 vs ASSURE Wearable ECG

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Kestra Medical Technologies

AI Verdict

Tool A is an AI-powered 3D cardiac mapping and navigation system designed for electrophysiologists performing interventional procedures in a lab setting. In contrast, Tool B is a wearable ECG device for continuous, remote heart rate monitoring and data collection for at-risk cardiac patients. While both leverage AI in cardiology, Tool A focuses on procedural guidance and diagnosis during interventions, whereas Tool B specializes in long-term, non-invasive patient surveillance.

Choose CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 if…

Choose CARTO™ 3 EP Navigation System Software V8.0 if your electrophysiology lab requires an advanced, AI-powered 3D cardiac mapping and navigation system for invasive diagnostic and therapeutic procedures. This tool is ideal for electrophysiologists performing complex ablations for arrhythmias like AFib and VT, needing precise catheter visualization and high-resolution anatomical mapping. It is designed to enhance diagnostic accuracy and treatment efficacy during interventional cardiac procedures.

View CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 →

Choose ASSURE Wearable ECG if…

Choose ASSURE Wearable ECG if you need a non-invasive, continuous heart rate monitoring solution for at-risk cardiac patients in an outpatient or home setting. This wearable device is best suited for long-term remote patient monitoring, providing clinicians with automatic episode storage, alert-based notifications, and physiologic trend data through a cloud-based platform. It is designed for ongoing surveillance and early detection of cardiac events outside of the EP lab.

View ASSURE Wearable ECG →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 ASSURE Wearable ECG
Deployment On-premise (system with specialized hardware) The ASSURE system is intended for use by a patient during their normal daily activities primarily in the home or community setting, but also hospitals, medical clinics, healthcare facilities and transport.
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ASSURE Wearable ECG

Tool B emphasizes intuitive design and patient comfort with its wearable nature and SensorFit Garment, making it highly usable for its primary patient users in a home environment. While Tool A offers streamlined workflows for clinicians in a specialized setting, Tool B's focus on broad patient accessibility and ease of adoption gives it an edge in general usability.

Clinical Value

CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00

Tool A directly enhances the precision and efficacy of complex, invasive cardiac ablation procedures through advanced AI/ML for real-time 3D mapping and signal analysis. This direct involvement in critical treatment decisions and execution offers a more immediate and profound clinical impact on specific procedural outcomes compared to Tool B's continuous monitoring for management and early detection.

Pricing & Value

Tie

Both tools have opaque pricing models that require direct consultation with sales representatives. Without publicly available pricing information, it is impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value.

Enterprise Readiness

CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00

Tool A, as a foundational and critical system for electrophysiology labs from a major medical device company (Biosense Webster, part of Johnson & Johnson), implies a higher degree of established enterprise integration, IT support, and regulatory compliance within large hospital systems. Its on-premise deployment with cloud options caters to the complex infrastructure of surgical environments.

Innovation

CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00

Tool A demonstrates a more advanced and complex application of AI and deep learning for real-time surgical guidance, 3D anatomical mapping, and signal analysis in a high-stakes interventional setting. While Tool B's Adaptive Patient Intelligence for artifact filtering in wearables is innovative, Tool A's integration of AI into complex procedural decision-making represents a greater leap in healthcare AI application.

Support & Docs

ASSURE Wearable ECG

Tool B offers explicitly detailed and accessible support for its primary users, including a 24/7 ASSURE Helpline and in-person patient training by specialists to ensure proper fit and usage. This comprehensive and direct patient-centric support structure is a significant advantage for a wearable device designed for home use.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 ASSURE Wearable ECG
Name CARTOu2122 3 EP Navigation System Software V8.0 (FG-5400-00 ASSURE Wearable ECG
Company Biosense Webster, Inc. Kestra Medical Technologies
Description The CARTOu2122 3 EP Navigation System Software V8.0 by Biosense Webster is an FDA-cleared, AI-powered 3D cardiac mapping and navigation system for electrophysiologists, enhancing diagnosis and treatment of heart rhythm disorders like AFib and VT. Kestra Medical Technologies offers the ASSURE Wearable ECG, a non-therapeutic device for continuous heart rate monitoring and data collection, integrated into their digital healthcare platform for at-risk cardiac patients.
Categories Cardiology AI, Surgical AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Key Features Advanced Catheter Location (ACL) technology for accurate catheter visualization, Fast Anatomical Mapping (FAM) for rapid, high-resolution 3D cardiac maps, Connection of Choice for streamlined workflow and automatic catheter recognition, CARTO ELEVATEu2122 Module with machine learning for enhanced signal analysis and substrate characterization, CARTOSOUNDu2122 FAM Module utilizing AI/deep-learning for automated 3D left atrial anatomy creation, Enhanced CONFIDENSEu2122 Module for optimized map creation and data validation, LAT Velocity Vectors for visualizing activation wave velocity over substrate maps, Stability+ algorithm for continuous analysis of ablation catheter movement Wearable ECG device for continuous heart rate monitoring, SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors, ASSURE Detection Algorithm with Quad Channel Processingu2122, Adaptive Patient Intelligenceu2122 for filtering motion artifacts, Automatic episode storage, Alert-based notifications, Physiologic trend data, Kestra CareStation remote patient data platform for clinician review

Videos

Demos, reviews, and walkthroughs featuring CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 and ASSURE Wearable ECG.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The CARTOu2122 3 EP Navigation System is an AI-powered 3D cardiac mapping and navigation system designed for electrophysiologists to enhance the diagnosis and treatment of heart rhythm disorders like AFib and VT during in-lab procedures. In contrast, the ASSURE Wearable ECG is a non-therapeutic device for continuous heart rate monitoring and data collection for at-risk cardiac patients, primarily for remote monitoring in home or community settings.
CARTOu2122 3 leverages AI and machine learning for enhanced signal analysis, substrate characterization (CARTO ELEVATEu2122 Module), and automated 3D left atrial anatomy creation (CARTOSOUNDu2122 FAM Module), including the first FDA-cleared AI algorithm in intracardiac ultrasound. The ASSURE Wearable ECG employs AI through its ASSURE Detection Algorithm with Quad Channel Processingu2122 and Adaptive Patient Intelligenceu2122 for filtering motion artifacts and analyzing heart rate and rhythm.
CARTOu2122 3 is suited for patients undergoing catheter-based cardiac electrophysiological procedures for heart rhythm disorders requiring advanced 3D cardiac mapping and navigation in an EP lab setting. The ASSURE Wearable ECG is intended for adult patients prescribed by a medical professional, particularly those previously using the ASSURE Wearable Cardioverter Defibrillator (WCD), who require continuous heart rate monitoring and remote data collection for various cardiac conditions.
CARTOu2122 3 collects and displays data for 3D anatomical and electroanatomical maps of the heart, catheter location, and intracardiac ECG signals to aid in diagnosis and treatment. The ASSURE Wearable ECG continuously monitors heart rate information, automatically stores episode data for high and low heart rates and patient-triggered events, and provides physiologic trend data for clinician review via the Kestra CareStation platform.

Backers

Who funded each tool's parent company.

ASSURE Wearable ECG

AI Tool Finder
AI-powered search. Results may not be comprehensive.